WorkowskiK. I., BachmannL. H., ChanP. A., JohnstonC. M., MuznyC. A., ParkI., RenoH., ZenilmanJ. M., & BolanG. A. (2021). Sexually transmitted infections treatment guidelines, 2021. Morbidity and Mortality Weekly Report, 70(4), 1–187. https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf
2.
SpauldingA. C., RabeeahZ., Del Mar González-MontalvoM., AkiyamaM. J., BakerB. J., BauerH. M., GibsonB. R., NijhawanA. E., ParvezF., WanguZ., & ChanP. A., and the Rollins Investigational Team on STIs in Corrections. (2022). Prevalence and management of sexually transmitted infections in correctional settings: A systemic review. Clinical Infectious Diseases, 74(Suppl_2), S193–S217. 10.1093/cid/ciac122
3.
Centers for Disease Control and Prevention. (2022). At-a-glance: CDC recommendations for correctional and detention settings testing, vaccination, and treatment for HIV, viral hepatitis, TB, and STIs. https://stacks.cdc.gov/view/cdc/120256
TerraultN. A., LokA. S. F., McMahonB. J., ChangK. M., HwangJ. P., JonasM. M., BrownR. S., BzowejN. H., & WongJ. B. (2018). Update on prevention, diagnosis, and treatment of chronic hepatitis B: AALSD 2018 hepatitis B guidance. Hepatology (Baltimore, Md.), 67(4), 1560–1599. 10.1002/hep.29800
6.
American Association for the Study of Liver Diseases/Infectious Disease Society of America. (n.d.). HCV guidance: Recommendations for testing, managing, and treating hepatitis C. https://www.hcvguidelines.org
7.
U.S. Public Health Service. (2021). Preexposure prophylaxis for the prevention of HIV infection in the United States—2021 update. https://stacks.cdc.gov/view/cdc/112360
8.
BachmannL. H., BarbeeL. A., ChanP., RenoH., WorkowskiK. A., HooverK., MerminJ., & MenaL. (2024). CDC clinical guidelines on the use of doxycycline postexposure prophylaxis for bacterial sexually transmitted infection prevention, United States, 2024. Morbidity and Mortality Weekly Report, 73(2), 1–8. https://www.cdc.gov/mmwr/volumes/73/rr/rr7302a1.htm
